https://openbell.ai/ 2026-10-01T15:02:23.798Z hourly 1.0 https://openbell.ai/support 2026-10-01T15:02:23.798Z monthly 0.7 https://openbell.ai/privacy 2026-10-01T15:02:23.798Z monthly 0.5 https://openbell.ai/terms 2026-10-01T15:02:23.798Z monthly 0.5 https://openbell.ai/feed.json 2026-10-01T15:02:23.798Z hourly 0.8 https://openbell.ai/news/USO:1790866864678 2026-10-01T15:01:04.678Z daily 0.9 https://cdn.brandfetch.io/USO/w/400/h/400?c=1idopYfmtR7ZKg8QMud Reported Earlier: "Chinese refiners suspend October fuel exports to bolster stocks, sources say"- Reuters Chinese refiners have suspended fuel exports for October in an effort to bolster domestic stocks, according to sources. This decision includes PetroChina, which has canceled several cargoes. The move is expected to impact global fuel supply and may influence market dynamics, particularly for companies reliant on fuel imports. https://openbell.ai/news/BTCUSD:1790866820355 2026-10-01T15:00:20.355Z daily 0.9 https://cdn.brandfetch.io/BTCUSD/w/400/h/400?c=1idopYfmtR7ZKg8QMud Is Bitcoin the Best Bet for Q4? An 'Epic Run' May Be Ahead, Expert Says Bitcoin (BTC) experienced a 40% gain in Q3, with Abra CEO Bill Barhydt predicting further growth in Q4, citing factors such as scarcity and improving market structure. He noted that Bitcoin's recent performance has outpaced traditional assets, with strong ETF inflows and a significant purchase of 1,665 BTC contributing to the rally. Barhydt emphasizes Bitcoin's fixed scarcity amidst increasing fiat supply, which he believes enhances its value, while also suggesting that the current rally is characterized by lower leverage and reduced volatility compared to previous speculative movements. https://openbell.ai/news/NXL:1790866667716 2026-10-01T14:57:47.716Z daily 0.9 https://cdn.brandfetch.io/NXL/w/400/h/400?c=1idopYfmtR7ZKg8QMud Nexalin Technology shares are trading higher after the company announced signing of a 10-year exclusive distribution agreement covering Brazil, Argentina, Chile, Uruguay, Paraguay, Ecuador and Venezuela. openbell Financial News https://openbell.ai/news/FHTX:1790866506399 2026-10-01T14:55:06.399Z daily 0.9 https://cdn.brandfetch.io/FHTX/w/400/h/400?c=1idopYfmtR7ZKg8QMud Foghorn Therapeutics shares are trading lower after the company and Lilly decided not to advance FHD-909 into the expansion phase and discontinued their SMARCA2 degrader collaboration. openbell Financial News https://openbell.ai/news/SYRE:1790866501539 2026-10-01T14:55:01.539Z daily 0.9 https://cdn.brandfetch.io/SYRE/w/400/h/400?c=1idopYfmtR7ZKg8QMud JP Morgan Initiates Coverage On Spyre Therapeutics with Overweight Rating, Announces Price Target of $110 JP Morgan analyst Hardik Parikh has initiated coverage on Spyre Therapeutics (NASDAQ: SYRE) with an Overweight rating. The firm has set a price target of $110 for the stock. https://openbell.ai/news/IVAI:1790866475722 2026-10-01T14:54:35.722Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/01/Veteran-Economist-Says-Buy-The-Dip-In-AI.jpg?width=250&height=187 Dan Ives Names 3 Under the Radar AI Stocks: ‘Starting to Get a Renaissance of Growth’ Tech analyst Dan Ives has identified three under-the-radar AI stocks: Dell Technologies (NYSE: DELL), Cisco Systems (NASDAQ: CSCO), and Hewlett Packard Enterprise (NYSE: HPE). He suggests these companies are experiencing a 'renaissance of growth' as the second, third, and fourth derivatives of AI begin to emerge. Ives also mentioned that these established firms may pursue acquisitions to enhance their positions in the AI sector, highlighting the broader potential for growth across the tech industry. https://openbell.ai/news/AISP:1790866366162 2026-10-01T14:52:46.162Z daily 0.9 https://cdn.brandfetch.io/AISP/w/400/h/400?c=1idopYfmtR7ZKg8QMud Airship AI Holdings shares are trading higher after the company announced it has been awarded $29 million in firm-fixed-price contracts from an agency within the Department of Homeland Security. openbell Financial News https://openbell.ai/news/OBAI:1790866294023 2026-10-01T14:51:34.023Z daily 0.9 https://cdn.brandfetch.io/OBAI/w/400/h/400?c=1idopYfmtR7ZKg8QMud Our Bond shares are trading lower after the company announced a 1-for-20 reverse stock split. openbell Financial News https://openbell.ai/news/ACN:1790866258891 2026-10-01T14:50:58.891Z daily 0.9 https://cdn.brandfetch.io/ACN/w/400/h/400?c=1idopYfmtR7ZKg8QMud Shares of enterprise software companies are trading higher amid sympathy with Accenture after that company reported better-than-expected Q4 financial results and issued FY27 sales guidance above estimates. openbell Financial News https://openbell.ai/news/BTLN:1790866144328 2026-10-01T14:49:04.328Z daily 0.9 https://cdn.brandfetch.io/BTLN/w/400/h/400?c=1idopYfmtR7ZKg8QMud Brightline Interactive shares are trading higher after the company announced the closing of a $1.25 million PIPE financing led by Dr. Allan Evans. openbell Financial News https://openbell.ai/news/SEV:1790866045630 2026-10-01T14:47:25.630Z daily 0.9 https://cdn.brandfetch.io/SEV/w/400/h/400?c=1idopYfmtR7ZKg8QMud Aptera Motors shares are trading lower after the company said it still needs about $25 million to start production and $115 million to reach high-volume manufacturing, despite lowering its capital estimates. openbell Financial News https://openbell.ai/news/ELVN:1790865997926 2026-10-01T14:46:37.926Z daily 0.9 https://cdn.brandfetch.io/ELVN/w/400/h/400?c=1idopYfmtR7ZKg8QMud JP Morgan Initiates Coverage On Enliven Therapeutics with Overweight Rating, Announces Price Target of $75 JP Morgan analyst Priyanka Grover has initiated coverage on Enliven Therapeutics (NASDAQ: ELVN) with an Overweight rating. The firm has set a price target of $75 for the stock. https://openbell.ai/news/KURA:1790865921509 2026-10-01T14:45:21.509Z daily 0.9 https://cdn.brandfetch.io/KURA/w/400/h/400?c=1idopYfmtR7ZKg8QMud JP Morgan Initiates Coverage On Kura Oncology with Overweight Rating, Announces Price Target of $30 JP Morgan analyst Priyanka Grover has initiated coverage on Kura Oncology (NASDAQ: KURA) with an Overweight rating. The firm has set a price target of $30 for the company's stock. https://openbell.ai/news/LIFE:1790865692498 2026-10-01T14:41:32.498Z daily 0.9 https://cdn.brandfetch.io/LIFE/w/400/h/400?c=1idopYfmtR7ZKg8QMud Watching Ethos Technologies; Hunterbrook Media Issues Report Titled, “How Ethos Sold Wall Street on AI While Powering an Analog Boiler Room”; States Hunterbrook Capital Is Short $LIFE Hunterbrook Media has released a report titled 'How Ethos Sold Wall Street on AI While Powering an Analog Boiler Room,' which raises concerns about Ethos Technologies. The report indicates that Hunterbrook Capital is taking a short position on the stock of Ethos, trading under the ticker $LIFE. Specific financial figures or market impacts were not disclosed in the article. https://openbell.ai/news/NCI:1790865550200 2026-10-01T14:39:10.200Z daily 0.9 https://cdn.brandfetch.io/NCI/w/400/h/400?c=1idopYfmtR7ZKg8QMud Neo-Concept International shares are trading lower after the company announced a registered direct offering of 250,000 shares and 1.75 million pre-funded warrants priced at $1.00 per share equivalent. openbell Financial News https://openbell.ai/news/LIFE:1790865344279 2026-10-01T14:35:44.279Z daily 0.9 https://cdn.brandfetch.io/LIFE/w/400/h/400?c=1idopYfmtR7ZKg8QMud Watching Ethos Technologies; The Bear Cave Newsletter Issues Report On Co Titled "More Problems at Ethos (LIFE)" The Bear Cave Newsletter has released a report titled 'More Problems at Ethos (LIFE)', which highlights ongoing issues faced by Ethos Technologies. The report suggests that these problems could impact the company's performance and investor sentiment. Specific financial figures or strategic changes were not detailed in the article. https://openbell.ai/news/HSBC:1790864985747 2026-10-01T14:29:45.747Z daily 0.9 https://cdn.brandfetch.io/HSBC/w/400/h/400?c=1idopYfmtR7ZKg8QMud Shares of U.S.-listed UK banks are trading lower amid multiple catalysts including the pound falling to a three-month low and the 30-year gilt yield surpassing 6% for the first time since 1998. Also, further concerns for the economy such as inflation, the risks of rejoining the EU, an unclear BoE rates path, and government borrowing may dampen the outlook for lenders. openbell Financial News https://openbell.ai/news/FLNA:1790864756901 2026-10-01T14:25:56.901Z daily 0.9 https://cdn.brandfetch.io/FLNA/w/400/h/400?c=1idopYfmtR7ZKg8QMud Filana Therapeutics shares are trading higher after a Form 4 filing showed its President & CEO bought 306,813 shares at an average price of $0.91 each. openbell Financial News https://openbell.ai/news/WMG:1790864640796 2026-10-01T14:24:00.796Z daily 0.9 https://cdn.brandfetch.io/WMG/w/400/h/400?c=1idopYfmtR7ZKg8QMud UBS Maintains Buy on Warner Music Gr, Raises Price Target to $43 UBS analyst Batya Levi has reaffirmed a 'Buy' rating on Warner Music Group (NASDAQ: WMG) and increased the price target from $42 to $43. This adjustment reflects a positive outlook for the company in the market. https://openbell.ai/news/HOOD:1790864370945 2026-10-01T14:19:30.945Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/01/The-Robinhood-Trade.jpg?width=250&height=187 Robinhood Partners With Cboe on New Earnings Contracts: What's Going On? Robinhood and Cboe are set to launch new earnings contracts in October, making Robinhood the first retail broker to offer these SEC-regulated KPI binary options, pending regulatory approval. The initial rollout will include 23 actively traded US stocks, with both companies waiving fees on the contracts until the end of 2026. Cboe is also working to register its clearinghouse, Cboe Clear U.S., as a Covered Clearing Agency to facilitate these new contracts, indicating plans for broader clearing capabilities in the future. https://openbell.ai/news/DELL:1790864366098 2026-10-01T14:19:26.098Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/01/Japanese-flag.jpg?width=250&height=187 Dell Joins $15 Billion Japan AI Data Center Project as AI Infrastructure Spending Keeps Surging Dell Technologies Inc. is participating in a $15 billion AI data center project in Japan, collaborating with JERA and UK developer RHAELM. The facility, located near Tokyo, will have a capacity of up to 400 megawatts and is designed to expedite the availability of computing power by drawing electricity directly from an adjacent power station. Dell has reported record AI-server orders of $60.9 billion and anticipates $74 billion in AI-server revenue by fiscal 2027, with a backlog of $95 billion. The project aims to establish a scalable model for future AI infrastructure across Japan. https://openbell.ai/news/NKE:1790864353685 2026-10-01T14:19:13.685Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/01/Passive-Wearables-Offer-Alternative.jpg?width=250&height=187 Nike Stock Climbs Ahead of Q1 Earnings Nike Inc. (NYSE: NKE) shares rose 1.21% to $35.83 ahead of its first-quarter earnings report, expected to show revenue of $11.33 billion, down from $11.72 billion a year earlier. Analysts project earnings per share of 44 cents, down from 49 cents last year. Despite a history of exceeding revenue forecasts for seven consecutive quarters, the stock remains near its 52-week low of $35.15, reflecting investor concerns over product innovation and market performance. https://openbell.ai/news/DT:1790864350237 2026-10-01T14:19:10.237Z daily 0.9 https://cdn.brandfetch.io/DT/w/400/h/400?c=1idopYfmtR7ZKg8QMud UBS Maintains Buy on Dynatrace, Raises Price Target to $74 UBS analyst Radi Sultan has maintained a Buy rating on Dynatrace (NYSE: DT) and increased the price target from $65 to $74. This adjustment reflects a positive outlook on the company's performance. https://openbell.ai/news/HDB:1790864296487 2026-10-01T14:18:16.487Z daily 0.9 https://cdn.brandfetch.io/HDB/w/400/h/400?c=1idopYfmtR7ZKg8QMud HDFC Bank shares are trading higher after the company appointed ​Anup Bagchi as Managing Director and CEO starting in late October. The move removes a leadership speculation overhang for the stock. openbell Financial News https://openbell.ai/news/USO:1790864236396 2026-10-01T14:17:16.396Z daily 0.9 https://cdn.brandfetch.io/USO/w/400/h/400?c=1idopYfmtR7ZKg8QMud Reported Earlier, U.S. Tells France, Germany To Release Diesel Stocks Or Face U.S. Export Ban The U.S. government has urged France and Germany to release their diesel stockpiles, warning that failure to do so could result in a ban on U.S. diesel exports to these countries. This move is part of broader efforts to manage fuel supplies amid rising energy prices. The situation could significantly impact the diesel market and related industries in Europe. https://openbell.ai/news/ORA:1790864232972 2026-10-01T14:17:12.972Z daily 0.9 https://cdn.brandfetch.io/ORA/w/400/h/400?c=1idopYfmtR7ZKg8QMud UBS Downgrades Ormat Technologies to Neutral, Lowers Price Target to $100 UBS analyst Jon Windham has downgraded Ormat Technologies (NYSE: ORA) from a Buy rating to Neutral. The price target for the stock has been reduced from $157 to $100. https://openbell.ai/news/SOXX:1790864224201 2026-10-01T14:17:04.201Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/01/Artificial-Intelligence-Analyzing-Global.jpg?width=250&height=187 Wall Street’s Favorite AI Trade Is Up 89% This Year: Its Best Season Starts Today The iShares Semiconductor ETF (NASDAQ: SOXX) has risen 88.8% in 2026, making it the best-performing industry in the U.S. stock market this year. September was notably strong for chip stocks, with SOXX gaining 11.3%, its second-best September since 2001. Historically, the period from October to February has been the most favorable for semiconductor stocks, averaging a 12.5% return over the past 25 seasons, with a success rate of 84%. Bank of America has identified top chip picks for this season, including Nvidia, Intel, Micron, Marvell, and Lam Research, citing various catalysts for growth. https://openbell.ai/news/CAG:1790864180248 2026-10-01T14:16:20.248Z daily 0.9 https://cdn.brandfetch.io/CAG/w/400/h/400?c=1idopYfmtR7ZKg8QMud Evercore ISI Group Maintains In-Line on Conagra Brands, Raises Price Target to $14 Evercore ISI Group analyst David Palmer has maintained an In-Line rating on Conagra Brands (NYSE: CAG) and increased the price target from $13 to $14. This adjustment reflects the firm's outlook on the company's performance in the market. https://openbell.ai/news/SYRE:1790864130383 2026-10-01T14:15:30.383Z daily 0.9 https://cdn.brandfetch.io/SYRE/w/400/h/400?c=1idopYfmtR7ZKg8QMud BTIG Reiterates Buy on Spyre Therapeutics, Maintains $121 Price Target BTIG analyst Julian Harrison has reiterated a Buy rating on Spyre Therapeutics (NASDAQ: SYRE) and maintained a price target of $121 for the stock. No additional financial figures or strategic changes were mentioned in the article. https://openbell.ai/news/NFLX:1790863953150 2026-10-01T14:12:33.150Z daily 0.9 https://cdn.brandfetch.io/NFLX/w/400/h/400?c=1idopYfmtR7ZKg8QMud Guggenheim Maintains Buy on Netflix, Raises Price Target to $80 Guggenheim analyst Michael Morris has maintained a Buy rating on Netflix (NASDAQ: NFLX) and increased the price target from $75 to $80. This adjustment reflects a positive outlook for the company in the market. https://openbell.ai/news/ADPT:1790863818408 2026-10-01T14:10:18.408Z daily 0.9 https://cdn.brandfetch.io/ADPT/w/400/h/400?c=1idopYfmtR7ZKg8QMud Guggenheim Maintains Buy on Adaptive Biotechnologies, Raises Price Target to $32 Guggenheim analyst Subbu Nambi has maintained a 'Buy' rating on Adaptive Biotechnologies (NASDAQ: ADPT) and increased the price target from $25 to $32. https://openbell.ai/news/BLLN:1790863758994 2026-10-01T14:09:18.994Z daily 0.9 https://cdn.brandfetch.io/BLLN/w/400/h/400?c=1idopYfmtR7ZKg8QMud Guggenheim Maintains Buy on BillionToOne, Raises Price Target to $128 Guggenheim analyst Subbu Nambi has maintained a Buy rating on BillionToOne (NASDAQ: BLLN) and increased the price target from $125 to $128. https://openbell.ai/news/BRKR:1790863647244 2026-10-01T14:07:27.244Z daily 0.9 https://cdn.brandfetch.io/BRKR/w/400/h/400?c=1idopYfmtR7ZKg8QMud Guggenheim Maintains Buy on Bruker, Raises Price Target to $72 Guggenheim analyst Subbu Nambi has maintained a 'Buy' rating on Bruker (NASDAQ: BRKR) and increased the price target from $70 to $72. This adjustment reflects a positive outlook on the company's performance. https://openbell.ai/news/POAS:1790863599893 2026-10-01T14:06:39.893Z daily 0.9 https://cdn.brandfetch.io/POAS/w/400/h/400?c=1idopYfmtR7ZKg8QMud Phaos Technology Inks $10M Securities Purchase Agreement With High West Partners Phaos Technology Holdings (NYSE American: POAS) has entered into a securities purchase agreement with High West Partners LLC, allowing the company to sell up to $10 million of its Class A ordinary shares. The agreement, dated September 28, 2026, grants Phaos the right to sell shares at prevailing market prices, subject to specific terms and NYSE listing rules. https://openbell.ai/news/CAH:1790863545100 2026-10-01T14:05:45.100Z daily 0.9 https://cdn.brandfetch.io/CAH/w/400/h/400?c=1idopYfmtR7ZKg8QMud Cardinal Health shares are trading higher after the company reaffirmed its FY27 adjusted EPS guidance above estimates. openbell Financial News https://openbell.ai/news/ABBV:1790863459114 2026-10-01T14:04:19.114Z daily 0.9 https://cdn.brandfetch.io/ABBV/w/400/h/400?c=1idopYfmtR7ZKg8QMud AbbVie Presents Data From Its Current Phase 3 Viti-Up-1, Viti-Up-2 Trials Of RINVOQ At 2026 European Academy Of Dermatology And Venereology Congress AbbVie (NYSE: ABBV) presented late-breaking results from its Phase 3 Viti-Up-1 and Viti-Up-2 trials of RINVOQ (upadacitinib) for non-segmental vitiligo at the 2026 EADV Congress, demonstrating continued facial and total body repigmentation through week 76. Additionally, findings from a phototherapy substudy indicated that patients receiving RINVOQ combined with whole-body NB-UVB phototherapy had numerically higher repigmentation responses compared to those receiving RINVOQ alone. https://openbell.ai/news/OXY:1790863436939 2026-10-01T14:03:56.939Z daily 0.9 https://cdn.brandfetch.io/OXY/w/400/h/400?c=1idopYfmtR7ZKg8QMud Occidental Petroleum shares are trading higher after Goldman Sachs upgraded its rating on the stock from Neutral to Buy and raised its price target from $63 to $69. openbell Financial News https://openbell.ai/news/SPY:1790863247001 2026-10-01T14:00:47.001Z daily 0.9 https://cdn.brandfetch.io/SPY/w/400/h/400?c=1idopYfmtR7ZKg8QMud USA Construction Spending (MoM) For August 0.9% Vs 0.0% Est openbell Financial News https://openbell.ai/news/CYRX:1790863234676 2026-10-01T14:00:34.676Z daily 0.9 https://cdn.brandfetch.io/CYRX/w/400/h/400?c=1idopYfmtR7ZKg8QMud Guggenheim Maintains Buy on CryoPort, Raises Price Target to $19 Guggenheim analyst Subbu Nambi has maintained a Buy rating on CryoPort (NASDAQ: CYRX) and raised the price target from $16 to $19. This adjustment reflects a positive outlook for the company's stock performance. https://openbell.ai/news/SPY:1790863221665 2026-10-01T14:00:21.665Z daily 0.9 https://cdn.brandfetch.io/SPY/w/400/h/400?c=1idopYfmtR7ZKg8QMud ISM Manufacturing Prices For September 77.9 Vs 72.9 Est. openbell Financial News https://openbell.ai/news/DHR:1790863141261 2026-10-01T13:59:01.261Z daily 0.9 https://cdn.brandfetch.io/DHR/w/400/h/400?c=1idopYfmtR7ZKg8QMud Guggenheim Maintains Buy on Danaher, Raises Price Target to $250 Guggenheim analyst Subbu Nambi has maintained a Buy rating on Danaher (NYSE: DHR) and increased the price target from $200 to $250. This adjustment reflects a positive outlook for the company's performance. https://openbell.ai/news/GH:1790863024298 2026-10-01T13:57:04.298Z daily 0.9 https://cdn.brandfetch.io/GH/w/400/h/400?c=1idopYfmtR7ZKg8QMud Guggenheim Maintains Buy on Guardant Health, Raises Price Target to $200 Guggenheim analyst Subbu Nambi has maintained a 'Buy' rating on Guardant Health (NASDAQ: GH) and increased the price target from $190 to $200. This adjustment reflects a positive outlook on the company's performance. https://openbell.ai/news/GRAL:1790862912177 2026-10-01T13:55:12.177Z daily 0.9 https://cdn.brandfetch.io/GRAL/w/400/h/400?c=1idopYfmtR7ZKg8QMud Guggenheim Maintains Buy on GRAIL, Raises Price Target to $155 Guggenheim analyst Subbu Nambi has maintained a 'Buy' rating on GRAIL (NASDAQ: GRAL) and raised the price target significantly from $75 to $155. This adjustment reflects a positive outlook on the company's performance. https://openbell.ai/news/GOGO:1790862815544 2026-10-01T13:53:35.544Z daily 0.9 https://cdn.brandfetch.io/GOGO/w/400/h/400?c=1idopYfmtR7ZKg8QMud Gogo Says Court Overturned SmartSky's $22.7M Damages Award In Its Entirety Gogo Inc. announced that the U.S. District Court for the District of Delaware has overturned a jury's $22.7 million damages award to SmartSky Networks in its entirety, stating that SmartSky failed to prove any recoverable damages. The court found the damages award was not supported by the evidentiary record and relied on unsubstantiated assumptions. This ruling is a significant development for Gogo as it seeks to resolve the matter and refocus on its core business of providing connectivity technology for aviation customers. The ruling is subject to appeal. https://openbell.ai/news/ILMN:1790862805302 2026-10-01T13:53:25.302Z daily 0.9 https://cdn.brandfetch.io/ILMN/w/400/h/400?c=1idopYfmtR7ZKg8QMud Guggenheim Maintains Buy on Illumina, Raises Price Target to $305 Guggenheim analyst Subbu Nambi has maintained a Buy rating on Illumina (NASDAQ: ILMN) and raised the price target from $226 to $305. This adjustment reflects a positive outlook for the company in the market. https://openbell.ai/news/NTRA:1790862735886 2026-10-01T13:52:15.886Z daily 0.9 https://cdn.brandfetch.io/NTRA/w/400/h/400?c=1idopYfmtR7ZKg8QMud Guggenheim Maintains Buy on Natera, Raises Price Target to $475 Guggenheim analyst Subbu Nambi has maintained a Buy rating on Natera (NASDAQ: NTRA) and raised the price target from $360 to $475. This adjustment reflects a positive outlook on the company's performance. https://openbell.ai/news/TEM:1790862663975 2026-10-01T13:51:03.975Z daily 0.9 https://cdn.brandfetch.io/TEM/w/400/h/400?c=1idopYfmtR7ZKg8QMud Guggenheim Maintains Buy on Tempus AI, Raises Price Target to $92 Guggenheim analyst Subbu Nambi has maintained a Buy rating on Tempus AI (NASDAQ: TEM) and increased the price target from $65 to $92. This adjustment reflects a positive outlook on the company's performance. https://openbell.ai/news/TWST:1790862531024 2026-10-01T13:48:51.024Z daily 0.9 https://cdn.brandfetch.io/TWST/w/400/h/400?c=1idopYfmtR7ZKg8QMud Guggenheim Maintains Buy on Twist Bioscience, Raises Price Target to $212 Guggenheim analyst Subbu Nambi has maintained a Buy rating on Twist Bioscience (NASDAQ: TWST) and raised the price target from $107 to $212. This adjustment reflects a positive outlook on the company's performance. https://openbell.ai/news/NXL:1790862517626 2026-10-01T13:48:37.626Z daily 0.9 https://cdn.brandfetch.io/NXL/w/400/h/400?c=1idopYfmtR7ZKg8QMud Nexalin Technology Shares Halted On Circuit Breaker To The Upside, Stock Now Up 92.76% openbell Financial News https://openbell.ai/news/WAT:1790862443172 2026-10-01T13:47:23.172Z daily 0.9 https://cdn.brandfetch.io/WAT/w/400/h/400?c=1idopYfmtR7ZKg8QMud Guggenheim Maintains Buy on Waters, Raises Price Target to $490 Guggenheim analyst Subbu Nambi has maintained a Buy rating on Waters (NYSE: WAT) and increased the price target from $440 to $490. This adjustment reflects a positive outlook for the company's stock performance.